Consolidated statements of income and comprehensive income/loss (-)
(unaudited)
|
Six months ended 30 June |
|
|---|---|---|
(thousands of €, except per share data) |
2023 |
2022 |
Product net sales |
54,275 |
35,356 |
Collaboration revenues |
274,546 |
238,601 |
Total net revenues |
328,821 |
273,957 |
|
|
|
Cost of sales |
(7,840) |
(5,545) |
Research and development expenditure |
(211,875) |
(249,518) |
Sales and marketing expenses |
(58,261) |
(71,008) |
General and administrative expenses |
(63,336) |
(63,001) |
Other operating income |
23,770 |
17,637 |
Operating profit/loss (-) |
11,279 |
(97,478) |
|
|
|
Fair value adjustments and net currency exchange differences |
183 |
71,929 |
Other financial income |
33,726 |
4,015 |
Other financial expenses |
(3,270) |
(8,268) |
Profit/loss (-) before tax |
41,918 |
(29,802) |
|
|
|
Income taxes |
(13,610) |
(2,536) |
Net profit/loss (-) |
28,308 |
(32,338) |
|
|
|
Net profit/loss (-) attributable to: |
|
|
Owners of the parent |
28,308 |
(32,338) |
Basic and diluted income/loss (-) per share |
0.43 |
(0.49) |
The accompanying notes form an integral part of these condensed consolidated financial statements.
|
Six months ended 30 June |
|
|---|---|---|
(thousands of €) |
2023 |
2022 |
Net profit/loss (-) |
28,308 |
(32,338) |
Items that may be reclassified subsequently to profit or loss: |
|
|
Translation differences, arisen from translating foreign activities |
256 |
93 |
Other comprehensive income, net of income tax |
256 |
93 |
|
|
|
Total comprehensive income/ |
|
|
Owners of the parent |
28,564 |
(32,245) |
The accompanying notes form an integral part of these condensed consolidated financial statements.